Standards, options and recommendations (SOR) for clinical care of malignant thymoma;Standards, options et recommandations pour la prise en charge des patients atteints de tumeurs epitheliales du thymus

Bulletin du Cancer

Volumn 86, Issue 4, 1999, Pages 365-384

  Ruffié, Pierre ^a   Gory Delabaere, Guillaume ^b   Fervers, Béatrice ^b   Lehmann, Michel ^b   Regnard, Jean François ^c   Resbeut, Michel ^d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FNCLCC   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d INSTITUT PAOLI CALMETTES   (France)

Author keywords

Adult; Cancer; Chemotherapy; Guidelines; Malignant thymoma; Neoplasms; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINCRISTINE SULFATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; FOLLOW UP; HUMAN; MEDICAL INFORMATION; METASTASIS; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; REOPERATION; THYMECTOMY; THYMOMA; TUMOR BIOPSY;

ADULT; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; THYMOMA; THYMUS NEOPLASMS;

EID: 0032896742     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. Alguacil-Garcia A, Halliday WC. Thymic carcinoma with focal neuroblastoma differentiation. Am J Surg Pathol 1987; 11: 474-9.
2. Arriagada R, Bretel JJ, Caillaud JM, Carreta I., Gucrin RA, Laugier A, et al. Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 1984; 20: 69-74.
3. Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Am J Pathol 1988; 133: 615-22.
4. Bergh NP, Gatzinsky P, Larsson S, Lundin P, Ridell B. Tumors of die thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg 1978; 25: 91-8.
5. Berthaud P, Le Chevalier T, Tursz T. Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet 1990; 335: 1590.
6. Blumberg D, Burt ME, Bains MS, Downey RJ, Marrini N, Rusch V, et al. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 1998; 115: 303-8; discussion 308-9.
7. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60: 908-13.
8. Bonomi PD, Finkelstein D, Aisner S, Ertinger D. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993; 16: 342-5.
9. Bretel JJ. Staging and preliminary results of the Thymic Tumour Study Group. In: Sarrazin, Vrousos, Vincent, eds. 7th Cancer Research Workshop. Basel: Kargel, 1989.
10. Brown LR, Muhm JR, Gray JL. Radiographic detection of thymoma. Am J Roentgenol 1980; 134: 1181-8.
11. Chahinian AP. Thymomas and thymic tumors. In: Holland JF, Bast RC, Morton DL, Frci E, Kufe DW, Weichselbaum RR, eds. Cancer Medicine. Baltimore: Williams & Wilkins, 1996; 1827.
12. Chen JL, Weisbrod GL, Herman SJ. Computed tomography and pathologic correlations of thymic lesions. J Thorac Imaging 1988; 3: 61-5.
13. Ciernik IF, Meier U, Lutolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994; 12: 1484-90.
14. Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X. et al. Thymoma: Results of a multicentric retrospective series of 149 nonmetastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération nationale des centres de lutte contre le cancer. Radiother Oncol 1995; 34: 9-16.
15. Crucitti F, Doglietto GB, Bellantone R, Perri V, Tommasini O, Tonali, et al. Effects of surgical treatment in thymoma with myasthenia gravis: Our experience in 103 patients. J Surg Oncol 1992; 50: 43-6.
16. Curran WJ, Kornstein MJ, Brooks JJ, Turrisi AT. Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988; 6: 1722-7.
17. Dahan M, Gaillard J, Marry H, Renella-Coll J, Berjaud J. Long-term survival of surgically treated lympho-epithelial thymomas. Rev Mal Respir 1988; 5: 159-65.
18. Davies SE, Macartney JC, Camplejohn RS, Morris RW, Ring NP, Corrin B. DNA flow cytometry of thymomas. Histopathology 1989; 15: 77-83.
19. Davis RD, Oldham HN, Sabiston DC. Primary cysts and neoplasms of the mediastinum: Recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg 1987; 44: 229-37.
20. Dawson A, Ibrahim NB, Gibbs AR. Observer variation in the histopathological classification of thymoma: Correlation with prognosis. J Clin Pathol 1994; 47: 519-23.
21. Dimery IW, Lee JS, Blick M, Pearson G, Spitxer G, Hong WK. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 1988; 61: 2475-80.
22. Dorfman DM, Shahsafaei A, Chan JK. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 1997; 21: 936-40.
23. Ellis K, Austin JH, Jaretzki A. Radiologic detection of thymoma in patients with myasthenia gravis. Am J Roentgenol 1988; 151: 873-81.
24. Exbrayat C, Colonnat M, Menegoz F. In: Sarrazin, Vrousos, Vincent, eds. Descriptive Epidemiology of Thymoma. Basel: Kargel, 1989.
25. Fervers B, Bonichon F, Demard F, Heron JF, Mathoulin S, Philip T, et al. Méthodologie de développement des standards, options et recommandations diagnostiques et thérapeutiques en cancérologic. Bull Cancer 1995; 82: 761-7.
26. Fornasiero A, Daniele O, Ghiotto C, Sartori F, Rea F, Piazza M, et al. Chemotherapy of invasive thymoma. J Clin Oncol 1990; 8: 1419-23.
27. Fuentes P, Leude E, Ruiz C, Bordigoni L, Thomas P, Giudicelli R, et al. Treatment of thymomas. A report of 67 cases. Eur J Cardiothorac Surg 1992; 6: 180-7; discussion 188.
28. Fujimura S, Kondo T, Yamauchi A, Handa M, Nakada T. Experience with surgery for thymoma associated with pure red blood cell aplasia. Report of three cases. Chest 1985; 88: 221-5.
29. Fukai I, Funato Y, Mizuno T, Hashimoto T, Masaoka A. Distribution of thymic tissue in the mediastinal adipose tissue. J Thorac Cardiovasc Surg 1991; 101: 1099-102.
30. Gamondes JP, Balawi A, Greenland T, Adleine P, Mornex JF, Zhang J, et al. Seventeen years of surgical treatment of thymoma: Factors influencing survival. Eur J Cardiothorac Surg 1991; 5: 124-31.
31. Gerbino A, Berruti A, Tempellini M, Gorzegno G, Srivanello M, Birossi R. et al. Neoadjuvant chemotherapy with doxorubicin, cisplatin, vincristine, and cyclophosphamide (ADOC) in locally advanced thymonta. Proc Am Soc Clin Oncol 1998; 17 (abstract 1867).
32. Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and eroposide combination chentotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996; 14: 814-20.
33. Gordon MS, Battiato LA, Gonin R, Harrison-Mann BC, Loehrer PJ. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. J Immunother Emphasis Tumor Immunol 1995; 18: 179-84.
34. Gripp S, Hilgers K, Wurm R, Schmitt G. Thymoma: Prognostic factors and treatment outcomes. Cancer 1998; 83: 1495-503.
35. Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 1992; 54: 311-5.
36. Harper P, Highley N, Rankin E, Dussek J, Bryant B, Rowland C, et al. Ifosfamide monotherapy demonstrates high activity in malignant thymoma. Proc Am Soc Clin Oncol 1991; 10: (abstract 300).
37. Hasserjian RP, Klimstra DS, Rosai J. Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature. Am J Surg Pathol 1995; 19: 835-41.
38. Herman SJ, Holub RV, Weisbrod GL, Chamberlain DW. Anterior mediastinal masses: Utility of transthoracic needle biopsy. Radiology 1991; 180: 167-70.
39. Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994; 145: 268-75.
40. Ho FC, Fu KH, Lam SY, Chiu SW, Chan AC, Muller-Hermelink HK. Evaluation of a histogenetic classification for thymic epithelial tumours. Histopathology 1994; 25: 21-9.
41. Hsu CP, Chen CY, Chen CL, Lin CT, Hsu NY, Wang JH, et al. Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 1994; 107: 615-20.
42. Hu E, Levine J. Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 1986; 57: 1101-4.
43. Iezzoni J, Nass LB. Thymic basaloid carcinoma: A case report and review of the literature. Modern Pathology 1996; 9: 21-5.
44. Inghirami G, Chilosi M, Knowles DM. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am J Pathol 1990; 136: 1429-36.
45. Jackson MA, Ball DL. Post-operative radiotherapy in invasive thymoma. Radiother Oncol 1991; 21: 77-82.
46. Jaretzki A, Penn AS, Younger DS, Wolff M, Olarte MR, Lovelace RF, et al. « Maximal » thymectomy for myasthenia gravis. Results. J Thor Cardiovasc Surg 1988; 95: 747-57.
47. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Muller-Hermelink HK. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 1992; 16: 1153-69.
48. Kirkove C, Berghmans J, Noel II, van de Merckt J, Dramatic response of recurrent invasive thymoma to high doses of corticosteroids. Clin Oncol 1992; 4: 64-6.
49. Kirschner PA. Reoperation for thymoma: Report of 23 cases. Ann Thorac Surg 1990; 49: 550-4.
50. Komaki R, Putnam JB, Shin DM, Cox JD. Thymic neoplasms. Curr Opin Oncol 1997; 9: 156-60.
51. Kornstein MJ, Curran WJ, Turrisi AT, Brooks JJ. Cortical versus medullary thymomas: A useful morphologic distinction? Hum Pathol 1988; 19: 1335-9.
52. Krueger JB, Sagerman RH, King GA. Stage III thymoma: Results of postoperative radiation therapy. Radiology 1988; 168: 855-8.
53. Kubota K, Yamada S, Kondo T, Yamada K, Fukuda H, Fujiwara T, et al. PET imaging of primary mediastinal tumours. Br J Cancer 1996; 73: 882-6.
54. Kuo TT, Lo SK. Thymoma: A study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system. Hum Pathol 1993; 24: 766-71.
55. Latz D, Schraube P, Oppitz U, Kugler C, Manegold C, Flentje M, et al. Invasive thymoma: Treatment with postoperative radiation therapy. Radiology 1997; 204: 859-64.
56. Levasseur P, Khalil A, Menestrier M, Gaud C, Reignard J, Rojas-Miranda A, et al. First Intensive Radical Exeresis Surgery in Invasive Thymomas - Results from a Serie of 284 Operated Thymomas. Basel: Karger, 1989.
57. th Journées de Pathologie thoracique, Hôpital Marie-Lannelongue, 1992.
58. Levasseur P, Menestrier M, Gaud C, Darrevelle P, Julia P, Rojas-Miranda A, et al. Thymomas and associated diseases. À propos of a series of 255 surgically treated thymomas. Rev Mal Respir 1988; 5: 173-8.
59. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol 1978; 9: 495-515.
60. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma. A clinicopathologic review. Cancer 1987; 60: 2727-43.
61. Loehrer PJ, Jirourek M, Aisner S, Aisner J, Gruene MR, Thomas CR, et al. Phase II trial of etoposide (V), ifosfamide (I) plus cisplatin (P) in patients with advanced thymoma (T) or thymic carcinoma (TC): Preliminary results from an ECOG coordinated intergroup trial, Proc Am Soc Clin Oncol 1998; 17 (abstract 118).
62. Loehrer PJ, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-srage unresectable thymoma: An intergroup trial. J Clin Oncol 1997; 15: 3093-9.
63. Loehrer PJ, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994; 12: 1164-8.
64. Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991; 68: 706-13.
65. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: Results of 241 operated cases. Ann Thorac Surg 1991; 51: 152-6.
66. Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 1985; 407: 119-49.
67. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485-92.
68. Matsuno Y, Mukai K, Noguchi M, Sato Y, Shimosato Y. Histochemical and immunohistochemical evidence of glandular differentiation in thymic carcinoma. Acta Pathol Jpn 1989; 39: 433-8.
69. McReynolds SD, Gharagozloo CF, Leighton JA, Dausmann MA, Wesche DE, Pluth JR. Radical resection of malignant thymoma with reconstruction of the mediastinal venous confluence. J Cardiovasc Surg 1996; 37 (abstract 1): 83.
70. Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y. et al, Recurrence of thymoma: Clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985; 39: 165-9.
71. Moran CA, Suster S, Fishback NF, Kuss MN. Primary intrapulmonary thymoma. A clinicopathologic and immunohistochemical study of eight cases. Am J Surg Pathol 1995; 19: 304-12.
72. Moran CA, Travis WD, Rosado-de-Christenson M, Koss MN, Rosai J. Thymomas presenting as pleural tumors. Report of eight cases. Am J Surg Pathol 1992; 16: 138-44.
73. Mornex F, Resbeur M, Richaud P, Jung GM, Mirabel X, Marshal C, et al. Radiotherapy and chemotherapy for invasive thymomas: A multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération nationale des centres de lutte contre le cancer. Int J Radiat Oncol Biol Phys 1995; 32: 651-9.
74. Mulder DG, Herrmann C, Buckberg GD. Effect of thymectomy in patients with myasthenia gravis. A sixteen year experience. Am J Surg 1974; 128: 202-6.
75. Nakahara K, Ohno K, Hashimoto J, Macda H, Miyoshi S, Sakurai M, et al. Thymoma: Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 1041-7.
76. Osserman KE, Genkins G. Studies in myasthenia gravis: Review of a twenty-year experience in over 1 200 patients. Mt Sinai J Med 1971; 38: 497-537.
77. Pan CC, Wu HP, Yang CF, Chen WY, Chiang H. The clinicopathological correlation of epithelial subtyping in thymoma: A study of 112 consecutive cases. Hum Pathol 1994; 25: 893-9.
78. Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, et al. Thymoma. A retrospective study of 87 cases. Cancer 1994; 73: 2491-8.
79. Pescarmona E, Rendina EA, Venuta F, D'Arcangelo E, Pagani M, Ricci C, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990; 50: 534-8.
80. Pollack A, Komaki R, Cox JD, Ro JY, Oswald MJ, Shin DM, et al. Thymoma: Treatment and prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 1037-43.
81. Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL, Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994; 74: 606-17.
82. Quintanilla-Martinez L, Wilkins EW, Ferry JA, Harris NL. Thymoma-morphologic subclassification correlates with invasiveness and immunohistologic features: A study of 122 cases. Hum Pathol 1993; 24: 958-69.
83. Rea F, Sartori F, Loy M, Calabro F, Fornasiero A, Daniele O, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993; 106: 543-9.
84. Regnard JF, Magdeleina? P, Dromer C, Dulmet E, de Montpreville V, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: A series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376-84.
85. Regnard JF, Zinzindohoue F, Magdeleina? P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997; 64: 1593-8.
86. Resbeur M, Mornex F, Richaud P, Bachelot T, Jung G, Mirabel X, et al. Radiothérapie des thymomes. Étude de la littérature à propos d'une série rérospective et multicentrique de 149 cas. Bull Cancer Radiother 1995; 82: 9-19.
87. Rosai J, Levine G. Tumors of the Thymus. 2nd Serie Rev. Ed. Institute of Pathology, 1976.
88. Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavalto A, Cianci R, et al. Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997; 113: 55-63.
89. Saegesser F, Zoupanos G. [Thymoma and acquired immunologic deficiency in immunoglobulins]. Ann Chir Thorac Cardiovasc 1968; 7: 535-41.
90. Sakai F, Sone S, Kiyono K, Kawai T, Maruyama A, Ueda H, et al. MR imaging of thymoma: Radiologic-pathologic correlation. Am J Roentgenol 1992; 158: 751-6.
91. Salyer WR, Eggleston JC. Thymoma: A clinical and pathological study of 65 cases. Cancer 1976; 37: 229-49.
92. Schneider PM. Fellbaum C, Fink U, Bollschweiler E, Prauer HW. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 1997; 4: 46-56.
93. Shimizu N, Moriyama S, Aoe M, Nakata M, Ando A, Teramoto S. The surgical treatment of invasive thymoma, Resection with vascular reconstruction. J Thorac Cardiovasc Surg 1992; 103: 414-20.
94. Shimosato Y. Controversies surrounding the subclassification of thymoma. Cancer 1994; 74: 542-4.
95. Shin DM, Walsh GI, Komaki R, Putnam JB, Nesbitt J, Ro JY, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998; 129: 100-4.
96. Simeone JF, McCloud T, Putman CE, Marsh J, Thymoma and systemic lupus erythematous. Thorax 1975; 30: 697-700.
97. Slater G, Papatestas AE, Genkins G, Kornfeld P, Horowitz SH, Bender A. Thymomas in patients with myasthenia gravis. Ann Surg 1978; 188: 171-4.
98. Spigland N, Di Lorenzo M, Youssef S, Russo P, Brandt M. Malignant thymoma in children: A 20-year review. J Pediatr Surg 1990; 25: 1143-6.
99. Sugarbaker DJ. Thoracoscopy in the management of anterior mediastinal masses. Ann Thorac Surg 1993; 56: 653-6.
100. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996; 20: 1469-80.
101. Suster S, Moran CA. Primary thymic epithelial neoplasms: Current concepts and controversies. Anat Pathol 1997; 2: 1-19.
102. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 1991; 67: 1025-32.
103. Thomas de Montpreville V, Dulmet E, Thymomas and carcinoma of the thymus. Which classification should be used. Ann Pathol 1996; 16: 159-66.
104. Thomas de Montpreville V, Regnard JF, Magdeleinat P, Dulmet E, Levasseur P. [A new prognostic classification of thymomas (letter)]. [French]. Ann Pathol 1997; 17: 77.
105. Tomiak EM, Evans WK. The role of chemotherapy in invasive thymoma: A review of the literature and considerations for future clinical trials. Crit Rev Oncol Hematol 1993; 15: 113-24.
106. Trillet-Lenoir V, Brune J. Treatment of epithelial tumors of the thymus gland. Bull Cancer 1993; 80: 1043-50.
107. Uematsu M, Yoshida H, Kondo M, Itami J, Hatano K, Isobe K, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 1996; 35: 357-60.
108. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990; 19: 273-80.
109. Urgesi A, Monetti U, Rossi G, Ricardi U, Maggi G, Sannazzari GL, Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol 1992; 24: 221-5.
110. Venuta F, Rendina EA, Pescarmona EO, De Giacomo T, Vegna ML, Fazi P, et al. Multimodality treatment of thymoma: A prospective study. Ann Thor Surg 1997; 64: 1585-91; discussion 1591.
111. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985; 55: 1074-86.
112. Verley JM, Silbert D, Hollmann KH, Levasseur P. Histopathology and prognosis of thymomas. Statistical analysis of 200 cases. Rev Mal Respir 1988; 5: 179-85.
113. Wang CI, Taylor JS. In vitro evidence that UV-induced frameshift and substitution mutations at T tracts are the results of misalignment-mediated replication past a specific thymine dimer. Biochemistry 1992; 31: 3671-81.
114. Weide LG, Ulbright TM, Lochrer PJ, Williams SD. Thymic carcinoma A distinct clinical entity responsive to chemotherapy. Cancer 1993; 71: 1219-23.
115. White L, Grossman R, Tobias V. Effective chemotherapy for invasive thymoma and thymic carcinoma: Review of the literature. Cancer J 1990; 3: 110-2.
116. Wick MR. Assessing the prognosis of thymomas. Ann Thorac Surg 1990; 50: 521-2.
117. Wick MR, Scheithauer BW. Oat-cell carcinoma of the thymus. Cancer 1982; 49: 1652-7.
118. Wilkins EW. Thymoma: Surgical management. In: Wood DE, Thomas CR, eds. Mediastinal Tumors: Update, 1995. New York: Springer-Verlag, 1995: 11-8.
119. Wilkins EW, Grillo HC, Scannell JG, Moncure AC, Mathisen DJ. J. Maxwell Chamberlain Memorial Paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991; 51: 888-92.
120. Wu TC, Kuo TT. Study of Epstein-Barr virus early RNA 1 (EBER 1) expression by in situ hybridization in thymic epithelial tumors of Chinese patients in Taiwan. Hum Pathol 1993; 24: 235-8.
121. Yoshida H, Uematsu M, Itami J, Kondo M, Ito H, Kubo A, et al. The role of low-dose hemithoracic radiotherapy for thoracic dissemination of thymoma. Radiat Med 1997; 15: 399-403.